🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 19

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 19 of 20
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Oct 19, 2025 at 10:22 PM#91

One thing that is still open after rachel_ABQ’s answer:

How long did you give it before you decided it was working?

45 18VendorMark, COA_Karl, MikeFit_NJ and 42 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Oct 27, 2025 at 7:42 PM#92
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

I read this differently from Dr.PeteFamMed, on substance rather than tone. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

46 19traveltech_sara, AttorneyGrant, DebRD_ATL and 43 others
Reply Quote Save Share Report
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Nov 4, 2025 at 4:57 PM#93
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

47 20COA_Karl, MikeFit_NJ, InsuranceTom and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Nov 12, 2025 at 2:08 PM#94
Dr.PeteFamMed said:
One habit that pays for itself: post the method alongside the number.

That reframing is the part I needed.

48 21tammy_FL, Dr.LipidDallas, alex_tucson and 45 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Nov 20, 2025 at 11:14 AM#95

This was answered several pages up and is worth repeating rather than re-litigating:

If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

49 22kevin_tulsa, Dr.PainCLE, mike_mealprep and 46 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register